Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 32

Results For "FIND"

431 News Found

BGS Gleneagles Global Hospital unveils #SelfE campaign to fight breast cancer early
Healthcare | February 04, 2022

BGS Gleneagles Global Hospital unveils #SelfE campaign to fight breast cancer early

The objective behind introducing this extraordinary digital campaign is to spread awareness among Gen X and Z for the need of breast self-examination


More women than men open up on mental health issues: Krishna Veer Singh, Co-Founder & CEO, Lissun
interviews | February 02, 2022

More women than men open up on mental health issues: Krishna Veer Singh, Co-Founder & CEO, Lissun

Mental health issues are a cause for concern and in a conservative society like India. Thomas C Thottathil spoke to Krishna Veer Singh, Co-Founder and CEO of Lissun, a young start-up working in the space of mental health


CAS launches major biology expansion
Digitisation | February 01, 2022

CAS launches major biology expansion

The CAS SciFinder Discovery Platform expansion unlocks human-indexed insights from journals and patents in over 50 languages dating back to 1957 and 70 million biosequences curated by CAS scientists


Philips introduces at-home, 12-lead ECG integrated solution for trials
Medical Device | January 26, 2022

Philips introduces at-home, 12-lead ECG integrated solution for trials

Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials


Positive top-line results for bimekizumab in second phase 3 psoriatic arthritis study
Biotech | January 22, 2022

Positive top-line results for bimekizumab in second phase 3 psoriatic arthritis study

UCB plans to submit regulatory applications in Q3 2022


Green Valley receives US FDA approval for Phase II clinical trial for Parkinson’s disease
Biotech | January 17, 2022

Green Valley receives US FDA approval for Phase II clinical trial for Parkinson’s disease

The global multi-center phase-II clinical trial will be a 36-week, multi-center, randomized, double-blind, placebo-controlled trial, followed by a 36-week open-label extension period


AIIMS now uses ImmersiveTouch for surgeries
Digitisation | January 14, 2022

AIIMS now uses ImmersiveTouch for surgeries

Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training


Sinocompound and InCatT launch new Catalyst Screening Service
Biotech | January 12, 2022

Sinocompound and InCatT launch new Catalyst Screening Service

This service benefits pharmaceutical and fine chemical companies looking to optimise their reactions


Covaxin booster neutralises Omicron and Delta variants: Study
News | January 12, 2022

Covaxin booster neutralises Omicron and Delta variants: Study

The study will be published on the pre-print server, medRXiv, shortly


Mylab’s CoviSelf can detect Omicron: Study
Medical Device | January 10, 2022

Mylab’s CoviSelf can detect Omicron: Study

Recent Study by Columbia University finds Mylab’s CoviSelf can detect the Omicron variant successfully